DNA methods should be used to detect Chlamydia trachomatisBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7171.1525 (Published 28 November 1998) Cite this as: BMJ 1998;317:1525
View Full Text
- David Taylor-Robinson,
- Angela J Robinson
- Department of Genitourinary Medicine and Communicable Diseases, Imperial College School of Medicine at St Mary's, London W2 1NY
- Department of Genitourinary Medicine, Mortimer Market Centre, London WC1E 6AU
EDITOR—We agree with the comments1 on Boag and Kelly's editorial2 about the recommendations made by the chief medical officer's expert advisory group on Chlamydia trachomatis. We wish to raise another issue.
The laboratories associated with the genitourinary medicine clinics in the two pilot projects evaluating the proposed screening will use molecular procedures (ligase chain reaction or polymerase chain reaction) and not the less sensitive tests (enzyme immunoassays) …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.